Baxter Healthcare Corporation vs Respilon Production S.R.O.: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 209 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Respilon Production S.R.O..

Baxter Healthcare Corporation: 0 warning letters, 209 recalls, 0 approval records, 0 Form 483s.

Respilon Production S.R.O.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

Respilon Production S.R.O. — Warning letters1

Baxter Healthcare Corporation — Recalls209

Respilon Production S.R.O. — Recalls0

Baxter Healthcare Corporation — Approval records0

Respilon Production S.R.O. — Approval records0

Baxter Healthcare Corporation — Form 483s0

Respilon Production S.R.O. — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: August 19, 2026

Full history →

Respilon Production S.R.O.

Most recent FDA action: April 20, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs Respilon Production S.R.O.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-respilon-production-s-r-o

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗